NASDAQ:IDEX

Ideanomics Competitors

$2.95

-0.11 (-3.59 %)

(As of 04/9/2021 12:00 AM ET)

Add

Compare

Today's Range

$2.92

Now: $2.95▼

$3.04

50-Day Range

$2.66

MA: $3.15▼

$3.86

52-Week Range

$0.37

Now: $2.95▼

$5.53

Volume10.62 million shs

Average Volume41.94 million shs

Market Capitalization$704.96 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Ideanomics (NASDAQ:IDEX) Vs. ACCD, PHR, EVOP, EGOV, RPAY, and TTGT

Should you be buying IDEX stock or one of its competitors? Companies in the industry of "business services, not elsewhere classified" are considered alternatives and competitors to Ideanomics, including Accolade (ACCD), Phreesia (PHR), EVO Payments (EVOP), NIC (EGOV), Repay (RPAY), and TechTarget (TTGT).

Ideanomics vs. Accolade Stock

Accolade (NASDAQ:ACCD) and Ideanomics (NASDAQ:IDEX) are both business services companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, dividends, earnings and risk.

Insider and Institutional Ownership

34.7% of Accolade shares are owned by institutional investors. Comparatively, 4.7% of Ideanomics shares are owned by institutional investors. 21.5% of Ideanomics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Accolade and Ideanomics' gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Accolade	N/A	N/A	N/A	N/A	N/A
Ideanomics	$44.57 million	15.82	$-97,680,000.00	N/A	N/A

Accolade has higher earnings, but lower revenue than Ideanomics.

Analyst Ratings

This is a summary of recent recommendations and price targets for Accolade and Ideanomics, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Accolade	0	1	10	0	2.91
Ideanomics	0	0	0	0	N/A

Accolade currently has a consensus target price of $54.6364, suggesting a potential upside of 15.80%. Given Accolade's higher probable upside, equities research analysts clearly believe Accolade is more favorable than Ideanomics.

Profitability

This table compares Accolade and Ideanomics' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Accolade	N/A	N/A	N/A
Ideanomics	-998.07%	-212.69%	-116.68%

Summary

Accolade beats Ideanomics on 6 of the 8 factors compared between the two stocks.

Ideanomics vs. Phreesia Stock

Ideanomics (NASDAQ:IDEX) and Phreesia (NYSE:PHR) are both business services companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, risk, profitability and institutional ownership.

Insider and Institutional Ownership

4.7% of Ideanomics shares are owned by institutional investors. Comparatively, 75.4% of Phreesia shares are owned by institutional investors. 21.5% of Ideanomics shares are owned by company insiders. Comparatively, 28.2% of Phreesia shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares Ideanomics and Phreesia's revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ideanomics	$44.57 million	15.82	$-97,680,000.00	N/A	N/A
Phreesia	$124.78 million	19.03	$-20,290,000.00	($4.50)	-11.75

Phreesia has higher revenue and earnings than Ideanomics.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Ideanomics and Phreesia, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ideanomics	0	0	0	0	N/A
Phreesia	0	2	10	0	2.83

Phreesia has a consensus price target of $53.6429, suggesting a potential upside of 1.44%. Given Phreesia's higher possible upside, analysts plainly believe Phreesia is more favorable than Ideanomics.

Profitability

This table compares Ideanomics and Phreesia's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ideanomics	-998.07%	-212.69%	-116.68%
Phreesia	-16.37%	-16.07%	-11.18%

Summary

Phreesia beats Ideanomics on 10 of the 11 factors compared between the two stocks.

Ideanomics vs. EVO Payments Stock

Ideanomics (NASDAQ:IDEX) and EVO Payments (NASDAQ:EVOP) are both business services companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, risk, profitability and institutional ownership.

Insider and Institutional Ownership

4.7% of Ideanomics shares are owned by institutional investors. Comparatively, 52.7% of EVO Payments shares are owned by institutional investors. 21.5% of Ideanomics shares are owned by company insiders. Comparatively, 51.0% of EVO Payments shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares Ideanomics and EVO Payments' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ideanomics	$44.57 million	15.82	$-97,680,000.00	N/A	N/A
EVO Payments	$485.78 million	4.83	$-10,100,000.00	$0.66	42.98

EVO Payments has higher revenue and earnings than Ideanomics.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Ideanomics and EVO Payments, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ideanomics	0	0	0	0	N/A
EVO Payments	0	3	4	0	2.57

EVO Payments has a consensus price target of $27.2857, suggesting a potential downside of 3.82%. Given EVO Payments' higher possible upside, analysts plainly believe EVO Payments is more favorable than Ideanomics.

Profitability

This table compares Ideanomics and EVO Payments' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ideanomics	-998.07%	-212.69%	-116.68%
EVO Payments	-1.37%	-6.43%	2.97%

Summary

EVO Payments beats Ideanomics on 9 of the 11 factors compared between the two stocks.

Ideanomics vs. NIC Stock

Ideanomics (NASDAQ:IDEX) and NIC (NASDAQ:EGOV) are both business services companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, risk, profitability and institutional ownership.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Ideanomics and NIC, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ideanomics	0	0	0	0	N/A
NIC	1	2	0	1	2.25

NIC has a consensus price target of $30.50, suggesting a potential downside of 10.24%. Given NIC's higher possible upside, analysts plainly believe NIC is more favorable than Ideanomics.

Earnings & Valuation

This table compares Ideanomics and NIC's revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ideanomics	$44.57 million	15.82	$-97,680,000.00	N/A	N/A
NIC	$354.20 million	6.45	$50.43 million	$0.77	44.13

NIC has higher revenue and earnings than Ideanomics.

Insider and Institutional Ownership

4.7% of Ideanomics shares are owned by institutional investors. Comparatively, 89.7% of NIC shares are owned by institutional investors. 21.5% of Ideanomics shares are owned by company insiders. Comparatively, 2.7% of NIC shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Ideanomics and NIC's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ideanomics	-998.07%	-212.69%	-116.68%
NIC	14.94%	23.51%	15.34%

Summary

NIC beats Ideanomics on 9 of the 11 factors compared between the two stocks.

Ideanomics vs. Repay Stock

Repay (NASDAQ:RPAY) and Ideanomics (NASDAQ:IDEX) are both business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership.

Analyst Ratings

This is a breakdown of current ratings and price targets for Repay and Ideanomics, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Repay	0	1	12	0	2.92
Ideanomics	0	0	0	0	N/A

Repay presently has a consensus price target of $27.9231, suggesting a potential upside of 15.29%. Given Repay's higher possible upside, equities research analysts plainly believe Repay is more favorable than Ideanomics.

Earnings and Valuation

This table compares Repay and Ideanomics' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Repay	$104.60 million	20.38	$-40,030,000.00	N/A	N/A
Ideanomics	$44.57 million	15.82	$-97,680,000.00	N/A	N/A

Repay has higher revenue and earnings than Ideanomics.

Insider & Institutional Ownership

93.1% of Repay shares are held by institutional investors. Comparatively, 4.7% of Ideanomics shares are held by institutional investors. 16.5% of Repay shares are held by company insiders. Comparatively, 21.5% of Ideanomics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Repay and Ideanomics' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Repay	-12.06%	3.75%	2.07%
Ideanomics	-998.07%	-212.69%	-116.68%

Summary

Repay beats Ideanomics on 9 of the 11 factors compared between the two stocks.

Ideanomics vs. TechTarget Stock

TechTarget (NASDAQ:TTGT) and Ideanomics (NASDAQ:IDEX) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership.

Earnings and Valuation

This table compares TechTarget and Ideanomics' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TechTarget	$133.96 million	15.24	$16.88 million	$0.62	117.06
Ideanomics	$44.57 million	15.82	$-97,680,000.00	N/A	N/A

TechTarget has higher revenue and earnings than Ideanomics.

Profitability

This table compares TechTarget and Ideanomics' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TechTarget	12.90%	10.81%	7.48%
Ideanomics	-998.07%	-212.69%	-116.68%

Analyst Ratings

This is a breakdown of current ratings and price targets for TechTarget and Ideanomics, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TechTarget	0	1	5	0	2.83
Ideanomics	0	0	0	0	N/A

TechTarget presently has a consensus price target of $77.6667, suggesting a potential upside of 7.01%. Given TechTarget's higher possible upside, equities research analysts plainly believe TechTarget is more favorable than Ideanomics.

Insider & Institutional Ownership

84.6% of TechTarget shares are held by institutional investors. Comparatively, 4.7% of Ideanomics shares are held by institutional investors. 16.4% of TechTarget shares are held by company insiders. Comparatively, 21.5% of Ideanomics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

TechTarget beats Ideanomics on 9 of the 11 factors compared between the two stocks.